Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.

Chung DJ, Rossi M, Romano E, Ghith J, Yuan J, Munn DH, Young JW.

Blood. 2009 Jul 16;114(3):555-63. doi: 10.1182/blood-2008-11-191197. Epub 2009 May 22.

2.

Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.

Curti A, Trabanelli S, Onofri C, Aluigi M, Salvestrini V, Ocadlikova D, Evangelisti C, Rutella S, De Cristofaro R, Ottaviani E, Baccarani M, Lemoli RM.

Haematologica. 2010 Dec;95(12):2022-30. doi: 10.3324/haematol.2010.025924. Epub 2010 Aug 26.

3.

IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells.

Curran TA, Jalili RB, Farrokhi A, Ghahary A.

Immunobiology. 2014 Jan;219(1):17-24. doi: 10.1016/j.imbio.2013.06.008. Epub 2013 Jun 25.

PMID:
23891282
4.

Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?

Terness P, Chuang JJ, Bauer T, Jiga L, Opelz G.

Blood. 2005 Mar 15;105(6):2480-6. Epub 2004 Nov 30.

5.

Allogeneic Mature Human Dendritic Cells Generate Superior Alloreactive Regulatory T Cells in the Presence of IL-15.

Litjens NH, Boer K, Zuijderwijk JM, Klepper M, Peeters AM, Prens EP, Verschoor W, Kraaijeveld R, Ozgur Z, van den Hout-van Vroonhoven MC, van IJcken WF, Baan CC, Betjes MG.

J Immunol. 2015 Jun 1;194(11):5282-93. doi: 10.4049/jimmunol.1402827. Epub 2015 Apr 27.

6.

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.

Sharma MD, Baban B, Chandler P, Hou DY, Singh N, Yagita H, Azuma M, Blazar BR, Mellor AL, Munn DH.

J Clin Invest. 2007 Sep;117(9):2570-82.

7.

Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO.

Krause P, Singer E, Darley PI, Klebensberger J, Groettrup M, Legler DF.

J Leukoc Biol. 2007 Nov;82(5):1106-14. Epub 2007 Aug 14.

8.

Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells.

Jürgens B, Hainz U, Fuchs D, Felzmann T, Heitger A.

Blood. 2009 Oct 8;114(15):3235-43. doi: 10.1182/blood-2008-12-195073. Epub 2009 Jul 22.

9.

A distinct tolerogenic subset of splenic IDO(+)CD11b(+) dendritic cells from orally tolerized mice is responsible for induction of systemic immune tolerance and suppression of collagen-induced arthritis.

Park MJ, Park KS, Park HS, Cho ML, Hwang SY, Min SY, Park MK, Park SH, Kim HY.

Cell Immunol. 2012 Jul-Aug;278(1-2):45-54. doi: 10.1016/j.cellimm.2012.06.009. Epub 2012 Jul 10.

PMID:
23121975
10.
11.

Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model.

Park MJ, Min SY, Park KS, Cho YG, Cho ML, Jung YO, Park HS, Chang SH, Cho SG, Min JK, Park SH, Kim HY.

Arthritis Res Ther. 2008;10(1):R11. doi: 10.1186/ar2361. Epub 2008 Jan 25.

12.

Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells.

Sun J, Yu J, Li H, Yang L, Wei F, Yu W, Liu J, Ren X.

J Exp Clin Cancer Res. 2011 Sep 14;30:82. doi: 10.1186/1756-9966-30-82.

13.

Physiologic control of IDO competence in splenic dendritic cells.

Baban B, Chandler PR, Johnson BA 3rd, Huang L, Li M, Sharpe ML, Francisco LM, Sharpe AH, Blazar BR, Munn DH, Mellor AL.

J Immunol. 2011 Sep 1;187(5):2329-35. doi: 10.4049/jimmunol.1100276. Epub 2011 Aug 3.

14.

Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.

Mellor AL, Chandler P, Baban B, Hansen AM, Marshall B, Pihkala J, Waldmann H, Cobbold S, Adams E, Munn DH.

Int Immunol. 2004 Oct;16(10):1391-401. Epub 2004 Sep 6.

15.
16.

IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells.

Hill M, Tanguy-Royer S, Royer P, Chauveau C, Asghar K, Tesson L, Lavainne F, Rémy S, Brion R, Hubert FX, Heslan M, Rimbert M, Berthelot L, Moffett JR, Josien R, Grégoire M, Anegon I.

Eur J Immunol. 2007 Nov;37(11):3054-62.

17.

Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.

Yamazaki S, Inaba K, Tarbell KV, Steinman RM.

Immunol Rev. 2006 Aug;212:314-29. Review.

PMID:
16903923
18.

Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDO.

Williams CA, Harry RA, McLeod JD.

Immunology. 2008 May;124(1):89-101. Epub 2007 Dec 7.

19.

T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.

Kahler DJ, Mellor AL.

Handb Exp Pharmacol. 2009;(188):165-96. doi: 10.1007/978-3-540-71029-5_8. Review.

PMID:
19031026
20.

Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells.

Brenk M, Scheler M, Koch S, Neumann J, Takikawa O, Häcker G, Bieber T, von Bubnoff D.

J Immunol. 2009 Jul 1;183(1):145-54. doi: 10.4049/jimmunol.0803277. Epub 2009 Jun 17.

Items per page

Supplemental Content

Write to the Help Desk